Researchers also noticed that the use of resveratrol in the treatment of colon cancer cells led to a reduction in TGFβ1 and its downstream effector SMAD3, as explained by the action of miR-663 on TGFβ1 transcripts [54]. The gene discussed is TGFB1; the disease is colonic neoplasm.